feed,title,long_url,short_url
Benzinga,Delcath Systems' Hepzato Achieves 44% Best Overall Response Compared to Best Alternative Care in Eye Cancer,https://benzinga.com/general/biotech/21/06/21452416/delcath-systems-hepzato-achieves-44-best-overall-response-compared-to-best-alternative-care-in-ey,https://j.mp/3cooRJW
